Dr. Reddy's Laboratories Limited (BOM:500124)
India · Delayed Price · Currency is INR 1,322.70
+0.25 (0.02%)
At close: Sep 19, 2025
Dr. Reddy's Laboratories Employees
Dr. Reddy's Laboratories had 27,811 employees as of March 31, 2025. The number of employees increased by 763 or 2.82% compared to the previous year.
Employees
27,811
Change (1Y)
763
Growth (1Y)
2.82%
Revenue / Employee
12.02M INR
Profits / Employee
2.04M INR
Market Cap
1,101.01B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 27,811 | 763 | 2.82% |
| Mar 31, 2024 | 27,048 | 1,185 | 4.58% |
| Mar 31, 2023 | 25,863 | 1,068 | 4.31% |
| Mar 31, 2022 | 24,795 | 2,056 | 9.04% |
| Mar 31, 2021 | 22,739 | 1,089 | 5.03% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Reliance Industries | 403,303 |
| HDFC Bank | 214,521 |
| Bharti Airtel | 13,593 |
| Tata Consultancy Services | 607,979 |
| ICICI Bank | 182,665 |
| State Bank of India | 236,226 |
| Infosys | 323,578 |
| Bajaj Finance | 64,092 |
Dr. Reddy's Laboratories News
- 2 days ago - Dr Reddy shares in focus: India bulk drug makers reportedly start preparing for Ozempic patent expiry - Business Upturn
- 3 days ago - Dr. Reddy’s launches novel molecule ‘Tegoprazan’ in India for acid-related gastrointestinal diseases - Business Upturn
- 4 days ago - Nifty 50 top losers today, September 15: Cipla, Asian Paints, Mahindra & Mahindra, Shriram Finance, Dr. Reddy’s and more - Business Upturn
- 4 days ago - Dr. Reddy’s shares fall nearly 2% after USFDA issues Form 483 with 5 observations for Hyderabad unit - Business Upturn
- 4 days ago - Stocks in news today, Sept 15: HUL, HAL, Dr Reddy’s, Apollo Hospitals, Adani Power, APL, Engineers India, Railtel among key shares - Business Upturn
- 6 days ago - Dr. Reddy’s Laboratories receives Form 483 with five observations from USFDA after Bachupally facility inspection - Business Upturn
- 9 days ago - Dr. Reddy’s Laboratories acquires STUGERON portfolio from Janssen Pharmaceutica for $50.5 million - Business Upturn
- 10 days ago - Nifty 50 top gainers today, September 9: Infosys, Dr. Reddy’s Laboratories, Wipro, Adani Ports and more - Business Upturn